Janux Therapeutics (JANX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist

45.210
-1.180-2.54%

Close Nov 29 13:00 ET

45.210
0.0000.00%

Post 17:01 ET

2.37BMarket Cap-38641P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Seeking AlphaNov 29 12:00 ET
Janux Therapeutics Insider Sold Shares Worth $1,289,879, According to a Recent SEC Filing
MT NewswiresNov 29 03:20 ET
Janux Therapeutics To Host Virtual Event On Monday, December 2, 2024, At 4:30 PM ET Discussing Updated Clinical Data In Phase 1a Dose Escalation For JANX007 In MCRPC And Doses Selected For Phase 1b Expansion Studies
BenzingaNov 25 09:03 ET
Janux Therapeutics Initiated With an Outperform at Leerink
Yahoo FinanceNov 23 06:21 ET
Evaluating Janux Therapeutics: Insights From 6 Financial Analysts
BenzingaNov 22 11:00 ET
Janux Therapeutics Initiated at Outperform by Leerink Partners
Dow JonesNov 22 08:20 ET · Ratings

Comments

ApextradezCOM

Nov 22 08:03

More than a TRY2Save Alert

$Janux Therapeutics (JANX.US)$
lets go …. 79 solid pt and opportunities for profits off the current value (46.00)

103280143

Nov 18 07:51

A Glimpse into My 2025 Stock Picks (US Edition)

As we enter 2025, the U.S. stock market presents a landscape ripe with opportunities. The Federal Reserve's recent meeting minutes indicate a cautious yet optimistic approach, suggesting that while inflationary pressures are being monitored, the overall economic outlook remains positive. This balanced stance bodes well for investors seeking growth in the coming year.
Janux Therapeutics Inc. (NASDAQ: JANX)
Janux Therapeutics is a clinical-stage bioph...

Powell says no hurry for Fed rate cuts, how will you adjust your investment strategy?

SpeedyStud

Nov 17 18:33

Mid Month Update

Hey everyone! Like I mentioned in the last post, the big news is that MoomooCA has set up a server for me, and it's open for all of you to join! It’s called Trader’s Tavern, and yes—the profile pic is my cat <3
In there, I’ll be sharing more in-depth stock analysis, including entry and target points, plus detailed descriptions of each stock. It’d be great if you all could join us there!
In the meantime, here’s our mid-month update on some stocks I’m keeping an eye on! Let’s aim f...

Shaaaw

Jun 25 07:07

Here’s why I think that $MRK buys $JANX soon.

$Merck & Co (MRK.US)$ on the prowl for acquisitions up to $15 billion.
$Merck & Co (MRK.US)$ already has an active partnership with $Janux Therapeutics (JANX.US)$ for two TRACtr targets, and CEO Davis has evinced a preference for acquisition of $SPDR S&P Biotech ETF (XBI.US)$ in which $Merck & Co (MRK.US)$ already has a seat at the table.
$Merck & Co (MRK.US)$ acquisition of $HARP earlier this year (for a song) shows their interest in the T Cell engag...